Theoretical basis for the activity of thalidomide

BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
C MeierhoferC J Wiedermann

Abstract

The revival of thalidomide began shortly after the drug was withdrawn from the market because of its teratogenic properties. Therapeutic effects of thalidomide were found accidentally in leprosy patients with erythema nodosum leprosum (ENL). Subsequent research widened the understanding of the activity of thalidomide, and with improved methodology and the augmented background knowledge of immunology it was possible to interpret the properties of thalidomide more coherently. Effects on tumour necrosis factor-alpha (TNFalpha) release play an important role in the ability of thalidomide to affect the immune system. Alteration of synthesis and release of cytokines such as interleukin (IL)-1, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12 and interferon-gamma is involved in the complex mechanisms of thalidomide. Thalidomide targets leucocytes, endothelial cells and keratinocytes, affecting them in a different manner and at different cellular levels. Changes in the density of adhesion molecules alter leucocyte extravasation and the inflammatory response in the tissue involved. Several mechanisms for the teratogenic action of thalidomide are currently under review, but this mode of action of the drug still remains unclear and we review evidence...Continue Reading

References

Feb 8, 1992·Lancet·W Winter, E Frankus
Apr 1, 1992·Infection and Immunity·P F BarnesR L Modlin
Apr 16, 1992·The New England Journal of Medicine·G B VogelsangJ R Wingard
Mar 1, 1991·The Journal of Experimental Medicine·E P SampaioG Kaplan
Jan 1, 1990·European Surgical Research. Europäische Chirurgische Forschung. Recherches Chirurgicales Européennes·S EmreJ Hong
Apr 1, 1989·Journal of Autoimmunity·E CrainD B Drachman
Sep 1, 1988·Teratology·W Lenz
Apr 1, 1985·Nihon Rai Gakkai zasshi·T Koyama
May 1, 1986·Archives of Internal Medicine·J L JorizzoJ C Daniels
Sep 1, 1973·International Journal of Dermatology·F Londoño
Nov 15, 1967·Klinische Wochenschrift·M EllenriederW Krüpe
Jun 18, 1966·The Veterinary Record·W P Jaffe
Feb 28, 1970·British Medical Journal·P J MurphyT B Fitzgerald
Oct 1, 1965·Chemical & Pharmaceutical Bulletin·A TanakaG Urakubo
Oct 1, 1965·British Journal of Pharmacology and Chemotherapy·H SchumacherR T Williams
Sep 17, 1966·Nature·E O FieldK Hellmann
Jan 1, 1981·Scandinavian Journal of Immunology·E J ShannonR C Hastings
Jan 4, 1996·The New England Journal of Medicine·M Pasic, M Turina
Apr 26, 1994·Proceedings of the National Academy of Sciences of the United States of America·R J D'AmatoJ Folkman
May 1, 1995·Journal of the American Academy of Dermatology·M CarlesimoS Calvieri
Jan 1, 1995·The British Journal of Dermatology·L MeunierJ Meynadier
Jan 1, 1995·The British Journal of Dermatology·K U Schallreuter
Mar 1, 1995·Antimicrobial Agents and Chemotherapy·K V Clemons, D A Stevens
Feb 1, 1995·The Annals of Thoracic Surgery·K UthoffR S Stuart
Mar 15, 1994·Biochemical and Biophysical Research Communications·K NishimuraS Iwasaki
Dec 22, 1993·Molecular and Cellular Biochemistry·W B WeglickiT M Phillips

❮ Previous
Next ❯

Citations

Sep 2, 2005·Cancer Chemotherapy and Pharmacology·Christian ZimmermannJuergen Drewe
Feb 10, 2007·Current Treatment Options in Neurology·Barney J Stern, James Corbett
Aug 29, 2003·The Journal of Surgical Research·Shung-Haur YangJen-Hwey Chiu
Aug 8, 2013·Journal of Medicinal Chemistry·Jens-Uwe Peters
Oct 19, 2006·Mediators of Inflammation·Peng LvHesheng Luo
Feb 26, 2010·Pediatric Rheumatology Online Journal·Takako MiyamaeShumpei Yokota
Apr 13, 2002·Drugs & Aging·Shufeng ZhouJames W Paxton
Jun 27, 2008·Drugs·Christy B Doherty, Ted Rosen
Nov 28, 2002·Clinical and Experimental Immunology·J Rhodes
Sep 1, 2006·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·Shelley Chireyath PaulHe-Sheng Luo
May 29, 2004·Current Opinion in Neurology·Barney J Stern
Jul 9, 2008·Acta Oncologica·Lene W VestermarkLars Bastholt
Feb 28, 2002·Expert Opinion on Investigational Drugs·Ece A MutluAli Keshavarzian
May 5, 2010·International Immunopharmacology·Adel A GuirgisHussein S Agwa
Dec 26, 2009·Bioorganic & Medicinal Chemistry·Scott G StewartLawrence J Abraham
Sep 2, 2008·Seminars in Hematology·John P LeonardRebecca Elstrom
Dec 28, 2006·Journal of the American Academy of Dermatology·Christy Badgwell, Ted Rosen
Jun 3, 2004·Lancet·Michael E FranksWilliam D Figg
Oct 13, 2006·Pathology, Research and Practice·Peng LvShi-Quan Liu
Mar 10, 2004·The Journal of Pharmacy and Pharmacology·Koen VandenbroeckPatrick Matthys
Jul 27, 2002·Ophthalmic Plastic and Reconstructive Surgery·Zeynel A Karcioglu
Mar 22, 2003·The Korean Journal of Internal Medicine·Soo Jeong ChoiKye Won Kwon
Apr 25, 2003·Cancer Control : Journal of the Moffitt Cancer Center·Ivo W Tremont-Lukats, Mark R Gilbert
Jul 14, 2020·Dermatology : International Journal for Clinical and Investigative Dermatology·Sandra DomingoJosefina Cortés-Hernández

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.